Haemokinesis

Haemokinesis is an innovative biotechnology startup founded in 2010 in Australia with the slogan "When every second counts." The company specializes in delivering advanced blood diagnostic and testing technology for point-of-care (POC) and point-of-trauma (POT) blood diagnostics. Haemokinesis aims to address the limitations of existing human blood group testing in hospitals and blood banks by providing safe, fast, accurate, and reliable solutions. The company is committed to improving patient outcomes and saving lives by simplifying in-vitro diagnostic testing for medical professionals.

Haemokinesis is focused on removing the barriers of access to basic healthcare elements worldwide, with a specific emphasis on blood group testing and emergency medicine. The company's vision is to ensure that vital diagnostic technology is accessible to anyone, anywhere. With a focus on biotechnology and healthcare, Haemokinesis represents a promising investment opportunity in the field of medical technology and diagnostics. #EverySecondCounts #Haemokinesis #R&D #Immunohaematology